caffeine has been researched along with Diathesis in 128 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most commonly used laboratory test for predicting malignant hyperthermia susceptibility is the caffeine halothane contracture test." | 9.07 | Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry. ( Bunn, JS; Diaz, M; Landis, JR; Larach, MG, 1992) |
| " We evaluated whether toxic concentrations of cocaine altered the in vitro muscle response to halothane during contracture tests for MH." | 7.69 | Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. ( Brum, JM; DeBoer, GE; Mitsumoto, H; Sato, N, 1995) |
| "5 g/l in drinking water) on bicuculline- and pentylenetetrazol (PTZ)-induced seizures and c-fos expression were studied in mice." | 7.69 | Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. ( Fredholm, BB; Georgiev, V; Johansson, B; Kuosmanen, T, 1996) |
| "Two strains of inbred mice differed significantly in their susceptibility to tonic seizures induced by caffeine and the benzodiazepine inverse agonist, methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM)." | 7.67 | Different genes specify hyporesponsiveness to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM. ( Abla, KA; Carney, JM; Rennert, OM; Roderick, TH; Seale, TW, 1987) |
| "The in vitro halothane and caffeine contracture tests have been performed on muscle tissue from six survivors of the neuroleptic malignant syndrome." | 7.67 | Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests. ( Adnet, P; Guevart, E; Krivosic-Horber, R; Lestavel, P; Theunynck, D, 1987) |
| "Occurrence of seizures following long-term oral administration of caffeine (0." | 5.35 | Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine. ( Costentin, J; El Yacoubi, M; Ledent, C; Parmentier, M; Vaugeois, JM, 2008) |
| "The most commonly used laboratory test for predicting malignant hyperthermia susceptibility is the caffeine halothane contracture test." | 5.07 | Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry. ( Bunn, JS; Diaz, M; Landis, JR; Larach, MG, 1992) |
| "The thermogenic effect of an over-the-counter preparation containing 22 mg ephedrine, 30 mg caffeine and 50 mg theophylline was investigated in human volunteers with a predisposition to obesity and also in the lean." | 5.06 | The thermogenic properties of ephedrine/methylxanthine mixtures: human studies. ( Dulloo, AG; Miller, DS, 1986) |
| " However, experts worldwide agree that the only reference test to this day remains the in vitro halothane caffeine contracture tests." | 4.77 | [Screening tests for malignant hyperthermia susceptibility]. ( Adnet, P; Krivosic-Horber, R, 1989) |
| " Diagnosis is based on in vitro muscle contracture in response to halothane and/or caffeine exposure." | 3.70 | [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome]. ( Bahia, VS; Marchiori, PE; Oliveira, RA; Scaff, M; Silva, HC; Tsanaclis, AM, 2000) |
| "5 g/l in drinking water) on bicuculline- and pentylenetetrazol (PTZ)-induced seizures and c-fos expression were studied in mice." | 3.69 | Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. ( Fredholm, BB; Georgiev, V; Johansson, B; Kuosmanen, T, 1996) |
| " We evaluated whether toxic concentrations of cocaine altered the in vitro muscle response to halothane during contracture tests for MH." | 3.69 | Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. ( Brum, JM; DeBoer, GE; Mitsumoto, H; Sato, N, 1995) |
| " The halothane/caffeine contracture test was performed on the biopsied muscle." | 3.69 | Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. ( Britt, BA; Carr, AS; Cunliffe, M; Lerman, J; McLeod, ME, 1995) |
| "Early developmental exposure to caffeine in rats results in decreased susceptibility to certain chemically-induced seizures in the adult." | 3.69 | Neonatal caffeine exposure alters seizure susceptibility in rats in an age-related manner. ( Guillet, R, 1995) |
| "The in vitro contracture test determines the sensitivity of freshly obtained skeletal muscle specimens to caffeine or halothane applied to a bathing solution." | 3.68 | In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update. ( Gallagher, WJ; Iaizzo, PA; Wedel, DJ, 1991) |
| " In vitro, human MHS muscle samples were exposed to propofol and changes in (a) baseline tension and (b) contracture tension on exposure to halothane and caffeine were measured." | 3.68 | Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. ( Couchman, KG; McKenzie, AJ; Pollock, N, 1992) |
| "The in vitro halothane and caffeine contracture tests have been performed on muscle tissue from six survivors of the neuroleptic malignant syndrome." | 3.67 | Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests. ( Adnet, P; Guevart, E; Krivosic-Horber, R; Lestavel, P; Theunynck, D, 1987) |
| " The in vitro halothane-caffeine contracture tests are the most reliable method of identifying individuals susceptible to MH." | 3.67 | The association between the neuroleptic malignant syndrome and malignant hyperthermia. ( Adamantidis, MM; Adnet, PJ; Adnet-Bonte, CA; Dupuis, BA; Haudecoeur, G; Krivosic-Horber, RM; Saulnier, F, 1989) |
| "Two strains of inbred mice differed significantly in their susceptibility to tonic seizures induced by caffeine and the benzodiazepine inverse agonist, methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM)." | 3.67 | Different genes specify hyporesponsiveness to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM. ( Abla, KA; Carney, JM; Rennert, OM; Roderick, TH; Seale, TW, 1987) |
| " Halothane-caffeine contracture tests, interpreted in accordance with the criteria of the European Group on Malignant Hyperthermia, yielded the following results: 13 positive (MHS), 10 negative (MHN), 4 equivocal (MHE)." | 3.67 | [Tests of contracture and sensitivity to malignant hyperthermia in 27 patients]. ( Adamantidis, M; Adnet, P; Guévart, E; Krivosic, I; Krivosic-Horber, R; Theunynck, D, 1988) |
| "Patients with malignant hyperthermia susceptibility were classified into subgroups HH and HS (positive to halothane only and positive to both caffeine and halothane)." | 1.91 | Distinct pathophysiological characteristics in developing muscle from patients susceptible to malignant hyperthermia. ( Figueroa, L; Ibarra-Moreno, CA; Kraeva, N; Manno, C; Riazi, S; Rios, E; Tammineni, ER, 2023) |
| "The variable clinical presentation of malignant hyperthermia (MH), a disorder of calcium signalling, hinders its diagnosis and management." | 1.51 | Abnormal calcium signalling and the caffeine-halothane contracture test. ( Figueroa, L; Kraeva, N; Manno, C; Riazi, S; Ríos, E; Toro, S, 2019) |
| "To diagnose malignant hyperthermia (MH) susceptibility, muscle bundles are exposed to halothane and caffeine." | 1.37 | Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. ( Anetseder, M; Hartung, E; Metterlein, T; Roewer, N; Schuster, F, 2011) |
| "In vitro contracture testing to diagnose malignant hyperthermia (MH) susceptibility requires a muscle biopsy, which may be associated with severe side effects for the patient." | 1.35 | An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. ( Anetseder, M; Kranke, P; Metterlein, T; Muellenbach, RM; Negele, S; Roewer, N; Schuster, F; Schwemmer, U, 2008) |
| "In order to unveil long-lasting catalepsy refractoriness not attributable to the presence of caffeine in the brains of rats, they were evaluated from day 18 to day 27 after caffeine withdrawal, a time that is far in excess for the full excretion of a caffeine dose in this species." | 1.35 | Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine. ( Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL; Heredia-López, FJ; Moo-Puc, RE; Pineda, JC; Villanueva-Toledo, JR, 2009) |
| "Occurrence of seizures following long-term oral administration of caffeine (0." | 1.35 | Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine. ( Costentin, J; El Yacoubi, M; Ledent, C; Parmentier, M; Vaugeois, JM, 2008) |
| " MH susceptibility leads to a leftward shift of the dose-response curve for IM lactate after local injection of halothane and caffeine." | 1.33 | The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs. ( Anetseder, M; Hager, M; Müller, R; Roewer, N; Schöll, H; Schuster, F, 2006) |
| "Susceptibility to malignant hyperthermia is diagnosed by contracture test, which requires an open muscle biopsy sample." | 1.31 | Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test. ( Anetseder, M; Hager, M; Müller, CR; Roewer, N, 2002) |
| "These results suggest that human malignant hyperthermia (MH) is associated with reduced inhibition of the RYR by (i) cytosolic Mg(2+) and (ii) SR Ca(2+) depletion." | 1.31 | Effects of Mg(2+) and SR luminal Ca(2+) on caffeine-induced Ca(2+) release in skeletal muscle from humans susceptible to malignant hyperthermia. ( Duke, AM; Hopkins, PM; Steele, DS, 2002) |
| "The association between malignant hyperthermia (MH) and neuromuscular disorders is controversial." | 1.30 | Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study. ( Bittner, RE; Gilly, H; Mader, N, 1997) |
| "Chlorocresol was demonstrated to be a potent activator of Ca++ release from skeletal muscle sarcoplasmic reticulum." | 1.30 | [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients]. ( Adnet, PJ; Ben-Abraham, R; Haudcoeur, G; Krivosic-Horber, RM; Perel, A, 1997) |
| " The type of fibres (type I: oxidative, slow; type II: glycolytic, fast) were determined with strontium dose-response curves." | 1.30 | [Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia]. ( Adnet, P; Börtlein, ML; Etchrivi, T; Haudecoeur, G; Krivosic-Horber, R; Nivoche, Y; Tavernier, B, 1999) |
| " MHEh muscles revealed a dose-response curve similar to that found in MHN specimens." | 1.30 | Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol. ( Bittner, RE; Fricker, R; Gilly, H; Kress, HG; Musat, I; Steinbereithner, K, 1997) |
| "Caffeine sensitivity was defined as the threshold concentration inducing more than 10% of the maximal tension obtained with a calcium 1." | 1.29 | Fiber-type caffeine sensitivities in skinned muscle fibers from humans susceptible to malignant hyperthermia. ( Adamantidis, MM; Adnet, PJ; Bello, N; Bromberg, NL; Haudecoeur, G; Krivosic Horber, RM; Krivosic, I; Reyford, H, 1993) |
| "The altered caffeine sensitivity of malignant hyperthermia-susceptible (MHS) muscle contracture is one basis of the diagnostic test for this syndrome." | 1.29 | Caffeine stimulation of malignant hyperthermia-susceptible sarcoplasmic reticulum Ca2+ release channel. ( Louis, CF; Mickelson, JR; Shomer, NH, 1994) |
| "Caffeine sensitivity was studied in chemically skinned muscle fibers from vastus lateralis muscle obtained by biopsy during reconstructive knee surgery from 15 otherwise healthy young individuals." | 1.28 | Fiber-type specific caffeine sensitivities in normal human skinned muscle fibers. ( Andrish, JT; Bunge, G; Cruse, RP; DeBoer, GE; Mitsumoto, H; Tetzlaff, JE, 1990) |
| " In six MH(-) patients with previous masseter muscle rigidity, no adverse reactions occurred in response to volatile anesthetic agents." | 1.28 | Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. ( Allen, GC; Fletcher, JE; Rosenberg, H, 1990) |
| "Pre-treatment with ryanodine did not change the calcium signal brought about by halothane or ionomycin." | 1.28 | [Effects of halothane, caffeine and ryanodine on the intracellular calcium store in blood mononuclear cells]. ( Endo, M; Iino, M; Kawana, Y; Oyamada, H, 1992) |
| " In contrast, propranolol shifted the caffeine dose-response curve to the right and significantly increased the caffeine threshold in the MHS group." | 1.28 | Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle. ( Ording, H, 1989) |
| "A European Malignant Hyperpyrexia Group has been formed to facilitate exchange of information between centres performing in vitro muscle testing for malignant hyperpyrexia susceptibility." | 1.27 | A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. ( , 1984) |
| "The caffeine test was positive in 68% of MHS patients, 0." | 1.27 | Investigation of malignant hyperthermia in Denmark and Sweden. ( Fletcher, R; Ording, H; Ranklev, E, 1984) |
| "Malignant hyperthermia is a seemingly rare genetic myopathy." | 1.27 | Malignant hyperthermia in plastic surgery. ( Abdul-Rasool, IH; Dubrow, TJ; Lesavoy, MA; Wackym, PA, 1988) |
| "In vitro tests for the diagnosis of malignant hyperthermia susceptibility were performed in 105 patients and 20 normal controls according to the protocol of the European MH Group." | 1.27 | In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests. ( Ording, H; Skovgaard, LT, 1987) |
| "Ten additional patients had other muscle disorders (central core disease, hyperkalemic periodic paralysis, and Duchenne's muscular dystrophy) and abnormal IVCTs; six of the ten had elevated CK levels." | 1.27 | Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. ( Brownell, AK; Paasuke, RT, 1986) |
| "The father was found to be malignant hyperpyrexia-susceptible." | 1.27 | Malignant hyperpyrexia and sudden death. ( Fletcher, R; Krantz, P; Ranklev, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (28.13) | 18.7374 |
| 1990's | 61 (47.66) | 18.2507 |
| 2000's | 18 (14.06) | 29.6817 |
| 2010's | 9 (7.03) | 24.3611 |
| 2020's | 4 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, KJ | 1 |
| Sun, SA | 1 |
| Swan, C | 1 |
| Koenig, M | 1 |
| Derkay, CS | 1 |
| Figueroa, L | 2 |
| Kraeva, N | 3 |
| Manno, C | 2 |
| Ibarra-Moreno, CA | 1 |
| Tammineni, ER | 1 |
| Riazi, S | 3 |
| Rios, E | 2 |
| Li, J | 1 |
| Xiao, H | 1 |
| Luo, H | 1 |
| Tan, Y | 1 |
| Ni, Q | 1 |
| He, C | 1 |
| Magdalou, J | 1 |
| Chen, L | 1 |
| Wang, H | 1 |
| Sylvetsky, AC | 1 |
| Visek, AJ | 1 |
| Turvey, C | 1 |
| Halberg, S | 1 |
| Weisenberg, JR | 1 |
| Lora, K | 1 |
| Sacheck, J | 1 |
| Thompson, SJ | 1 |
| Noseworthy, MD | 1 |
| Rayner, TE | 1 |
| Schneiderman, JE | 1 |
| Cifra, B | 1 |
| Wells, GD | 1 |
| Toro, S | 1 |
| Silva, CG | 1 |
| Métin, C | 1 |
| Fazeli, W | 1 |
| Machado, NJ | 1 |
| Darmopil, S | 1 |
| Launay, PS | 1 |
| Ghestem, A | 1 |
| Nesa, MP | 1 |
| Bassot, E | 1 |
| Szabó, E | 1 |
| Baqi, Y | 1 |
| Müller, CE | 1 |
| Tomé, AR | 1 |
| Ivanov, A | 1 |
| Isbrandt, D | 1 |
| Zilberter, Y | 1 |
| Cunha, RA | 1 |
| Esclapez, M | 1 |
| Bernard, C | 1 |
| Roesl, C | 1 |
| Sato, K | 1 |
| Schiemann, A | 1 |
| Pollock, N | 2 |
| Stowell, KM | 1 |
| Sagui, E | 1 |
| Montigon, C | 1 |
| Abriat, A | 1 |
| Jouvion, A | 1 |
| Duron-Martinaud, S | 1 |
| Canini, F | 2 |
| Zagnoli, F | 1 |
| Bendahan, D | 2 |
| Figarella-Branger, D | 1 |
| Brégigeon, M | 1 |
| Brosset, C | 1 |
| Faingold, CL | 1 |
| Randall, M | 1 |
| Kommajosyula, SP | 1 |
| Hoppe, K | 1 |
| Hack, G | 1 |
| Lehmann-Horn, F | 5 |
| Jurkat-Rott, K | 1 |
| Wearing, S | 1 |
| Zullo, A | 1 |
| Carsana, A | 1 |
| Klingler, W | 2 |
| Schuster, F | 3 |
| Metterlein, T | 2 |
| Negele, S | 1 |
| Kranke, P | 1 |
| Muellenbach, RM | 1 |
| Schwemmer, U | 1 |
| Roewer, N | 7 |
| Anetseder, M | 6 |
| Silletta, MG | 1 |
| Marchioli, R | 1 |
| Góngora-Alfaro, JL | 1 |
| Moo-Puc, RE | 1 |
| Villanueva-Toledo, JR | 1 |
| Alvarez-Cervera, FJ | 1 |
| Bata-García, JL | 1 |
| Heredia-López, FJ | 1 |
| Pineda, JC | 1 |
| Tchekalarova, J | 2 |
| Kubová, H | 2 |
| Mares, P | 2 |
| Hartung, E | 3 |
| Duke, AM | 1 |
| Hopkins, PM | 6 |
| Steele, DS | 1 |
| Islander, G | 1 |
| Ording, H | 8 |
| Bendixen, D | 2 |
| Ranklev Twetman, E | 1 |
| Allen, PD | 1 |
| López, JR | 1 |
| Sei, Y | 1 |
| Brandom, BW | 1 |
| Bina, S | 2 |
| Hosoi, E | 1 |
| Gallagher, KL | 1 |
| Wyre, HW | 1 |
| Pudimat, PA | 1 |
| Holman, SJ | 1 |
| Venzon, DJ | 1 |
| Daly, JW | 1 |
| Muldoon, S | 2 |
| Wappler, F | 3 |
| Baur, CP | 1 |
| Censier, K | 2 |
| Doetsch, S | 1 |
| Felleiter, P | 1 |
| Fiege, M | 1 |
| Fricker, R | 2 |
| Halsall, PJ | 5 |
| Heffron, JJ | 2 |
| Heytens, L | 3 |
| Nivoche, Y | 2 |
| Tegazzin, V | 1 |
| Tzanova, I | 1 |
| Urwyler, A | 3 |
| Weisshorn, R | 1 |
| Schulte am Esch, J | 3 |
| Baker, PS | 1 |
| Textor, Z | 1 |
| Beer, M | 1 |
| Köstler, H | 1 |
| Kagerbauer, E | 1 |
| Kenn, W | 1 |
| Hahn, D | 1 |
| MENGUY, R | 1 |
| Ducreux, S | 1 |
| Zorzato, F | 1 |
| Müller, C | 1 |
| Sewry, C | 1 |
| Muntoni, F | 1 |
| Quinlivan, R | 1 |
| Restagno, G | 1 |
| Girard, T | 1 |
| Treves, S | 1 |
| Litman, RS | 1 |
| Rosenberg, H | 9 |
| Schöll, H | 1 |
| Hager, M | 2 |
| Müller, R | 1 |
| Bünger, R | 1 |
| El Yacoubi, M | 1 |
| Ledent, C | 1 |
| Parmentier, M | 1 |
| Costentin, J | 1 |
| Vaugeois, JM | 1 |
| Blanck, TJ | 1 |
| Gruener, RP | 1 |
| Ranklev, E | 4 |
| Fletcher, R | 4 |
| Reed, S | 1 |
| Nelson, TE | 2 |
| Flewellen, EH | 1 |
| Gloyna, DF | 1 |
| Steinfath, M | 1 |
| Singh, S | 1 |
| Scholz, J | 2 |
| Becker, K | 1 |
| Lenzen, C | 1 |
| Köchling, A | 2 |
| Sato, N | 1 |
| Brum, JM | 1 |
| Mitsumoto, H | 2 |
| DeBoer, GE | 2 |
| Bello, N | 2 |
| Adnet, P | 6 |
| Saulnier, F | 2 |
| Lestavel, P | 2 |
| Adnet-Bonte, C | 1 |
| Reyford, H | 2 |
| Etchrivi, T | 2 |
| Tavernier, B | 3 |
| Krivosic-Horber, R | 6 |
| Carr, AS | 1 |
| Lerman, J | 1 |
| Cunliffe, M | 1 |
| McLeod, ME | 1 |
| Britt, BA | 2 |
| Ducart, A | 1 |
| Renaud, B | 1 |
| Riou, B | 1 |
| Shomer, NH | 1 |
| Mickelson, JR | 1 |
| Louis, CF | 1 |
| O'Flynn, RP | 1 |
| Shutack, JG | 1 |
| Fletcher, JE | 5 |
| Kaufmann, MA | 1 |
| Drewe, J | 1 |
| Adnet, PJ | 7 |
| Krivosic-Horber, RM | 6 |
| Krivosic, I | 3 |
| Haudecoeur, G | 7 |
| Reyford, HG | 1 |
| Adamantidis, MM | 5 |
| Medahoui, H | 1 |
| Mortier, W | 1 |
| Breucking, E | 1 |
| Schrezenmeir, J | 1 |
| Keppler, I | 1 |
| Fenselau, S | 1 |
| Weber, P | 1 |
| Biesalski, HK | 1 |
| Probst, R | 1 |
| Laue, C | 1 |
| Zuchhold, HD | 1 |
| Prellwitz, W | 1 |
| Beyer, J | 1 |
| Bromberg, NL | 1 |
| Krivosic Horber, RM | 1 |
| Payen, JF | 1 |
| Bosson, JL | 1 |
| Bourdon, L | 2 |
| Jacquot, C | 1 |
| Le Bas, JF | 1 |
| Stieglitz, P | 1 |
| Benabid, AL | 1 |
| Ellis, FR | 4 |
| Guillet, R | 1 |
| Serfas, KD | 1 |
| Bose, D | 1 |
| Patel, L | 1 |
| Wrogemann, K | 1 |
| Phillips, MS | 1 |
| MacLennan, DH | 1 |
| Greenberg, CR | 1 |
| Sessler, DI | 1 |
| Johansson, B | 1 |
| Georgiev, V | 1 |
| Kuosmanen, T | 1 |
| Fredholm, BB | 1 |
| Kozak-Ribbens, G | 1 |
| Confort-Gouny, S | 1 |
| Cozzone, PJ | 1 |
| Stewart, AD | 1 |
| O'Brien, PJ | 2 |
| Li, G | 1 |
| Weglinski, MR | 1 |
| Wedel, DJ | 2 |
| Engel, AG | 1 |
| Gilly, H | 2 |
| Musat, I | 1 |
| Bittner, RE | 2 |
| Steinbereithner, K | 3 |
| Kress, HG | 1 |
| Bachand, M | 1 |
| Vachon, N | 1 |
| Boisvert, M | 1 |
| Mayer, FM | 1 |
| Chartrand, D | 1 |
| Ben-Abraham, R | 1 |
| Haudcoeur, G | 1 |
| Perel, A | 1 |
| Mader, N | 1 |
| Glahn, K | 1 |
| Gardi, T | 1 |
| Fagerlund, T | 1 |
| Cipriani, F | 1 |
| Geddes, M | 1 |
| Ummenhofer, W | 1 |
| Roesslein, R | 1 |
| Sutter, PM | 1 |
| Moser, N | 1 |
| Kern, C | 1 |
| Stewart, SH | 1 |
| Karp, J | 1 |
| Pihl, RO | 1 |
| Peterson, RA | 1 |
| Winkler, G | 1 |
| Schulte am Esch, JS | 1 |
| Etchrivi, TS | 1 |
| Diallo, A | 1 |
| Börtlein, ML | 1 |
| Silva, HC | 1 |
| Bahia, VS | 1 |
| Oliveira, RA | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| Tsanaclis, AM | 1 |
| Pastera, J | 1 |
| Anzenbacher, P | 1 |
| Fiala, Z | 1 |
| Müller, CR | 1 |
| Cosgrove, SB | 1 |
| Eisele, PH | 1 |
| Martucci, RW | 2 |
| Gronert, GA | 2 |
| McKenzie, AJ | 1 |
| Couchman, KG | 1 |
| Kawana, Y | 1 |
| Iino, M | 1 |
| Oyamada, H | 1 |
| Endo, M | 1 |
| Reyford, GH | 1 |
| Imbenotte, M | 1 |
| Cordonnier, C | 1 |
| Larach, MG | 2 |
| Landis, JR | 1 |
| Bunn, JS | 1 |
| Diaz, M | 1 |
| Martin, JJ | 1 |
| Van de Kelft, E | 1 |
| Bossaert, LL | 1 |
| Olthoff, D | 1 |
| Meinecke, CD | 1 |
| Preis, I | 1 |
| Engelhardt, W | 1 |
| Krauspe, R | 1 |
| Poels, PJ | 1 |
| Joosten, EM | 1 |
| Sengers, RC | 1 |
| Stadhouders, AM | 1 |
| Veerkamp, JH | 1 |
| Benders, AA | 1 |
| Iaizzo, PA | 4 |
| Gallagher, WJ | 1 |
| Rum, U | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Seewald, MJ | 1 |
| Eichinger, HM | 1 |
| Jaffe, RS | 1 |
| Elliott, TE | 1 |
| Cardinet, GH | 1 |
| Camu, F | 1 |
| Olgin, J | 1 |
| Allen, G | 1 |
| Seestedt, R | 1 |
| Chance, B | 1 |
| Klip, A | 1 |
| Mills, GB | 1 |
| Elliott, ME | 1 |
| Bunge, G | 1 |
| Andrish, JT | 1 |
| Tetzlaff, JE | 1 |
| Cruse, RP | 1 |
| Allen, GC | 2 |
| Huggins, FJ | 1 |
| Conti, PA | 1 |
| Reyfort, GH | 1 |
| Dupuis, BA | 2 |
| Kalow, BI | 1 |
| Ali, N | 1 |
| Lassaline, LA | 1 |
| Lumsden, JH | 1 |
| Kadlubar, FF | 1 |
| Talaska, G | 1 |
| Butler, MA | 1 |
| Teitel, CH | 1 |
| Massengill, JP | 1 |
| Lang, NP | 1 |
| Wieland, SJ | 1 |
| Gong, QH | 1 |
| Adnet-Bonte, CA | 1 |
| Foster, PS | 1 |
| Hopkinson, KC | 1 |
| Denborough, MA | 1 |
| Hackl, W | 2 |
| Winkler, M | 1 |
| Mauritz, W | 2 |
| Burket, RC | 1 |
| Hodgin, JD | 1 |
| Seale, TW | 1 |
| Abla, KA | 1 |
| Roderick, TH | 1 |
| Rennert, OM | 1 |
| Carney, JM | 1 |
| Wackym, PA | 1 |
| Dubrow, TJ | 1 |
| Abdul-Rasool, IH | 1 |
| Lesavoy, MA | 1 |
| Theunynck, D | 2 |
| Guévart, E | 2 |
| Adamantidis, M | 1 |
| Schreiber, GB | 1 |
| Robins, M | 1 |
| Maffeo, CE | 1 |
| Masters, MN | 1 |
| Bond, AP | 1 |
| Morganstein, D | 1 |
| Klein, W | 1 |
| Sporn, P | 1 |
| Graf, M | 1 |
| Sluga, E | 1 |
| Skovgaard, LT | 2 |
| Blomquist, S | 1 |
| Dulloo, AG | 1 |
| Miller, DS | 1 |
| Paasuke, RT | 1 |
| Brownell, AK | 1 |
| Gallant, EM | 1 |
| Fletcher, TF | 1 |
| Goettl, VM | 1 |
| Rempel, WE | 1 |
| Krantz, P | 1 |
| Monti, M | 1 |
| Ilias, WK | 1 |
| Williams, CH | 1 |
| Fulfer, RT | 1 |
| Dozier, SE | 1 |
| Fishbein, WN | 1 |
| Muldoon, SM | 1 |
| Deuster, PA | 1 |
| Armbrustmacher, VW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Freeman-Sheldon Syndrome Evaluation and Diagnosis in Clinical Settings (FSS-EDICT) I: a Case-Control, Cross-Sectional Study of Baseline and Stress Physiology Parameters[NCT01306994] | 0 participants (Actual) | Observational | 2014-03-31 | Withdrawn (stopped due to Lack of patient interest) | |||
| Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.[NCT00227097] | 300 participants | Observational | 2002-12-31 | Terminated | |||
| Evaluation of Diet and Treatment With a Combination of Ephedrine and Caffeine on Thermogenesis, Cardiac Function and on Uncoupling Proteins Expression in Adipose and Muscle Tissue of Morbid Obese Patients Undergoing Bariatric Surgery.[NCT02048215] | Phase 3 | 13 participants (Actual) | Interventional | 2000-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for caffeine and Diathesis
| Article | Year |
|---|---|
[Coffee and cardiovascular disease risk: yin and yang].
Topics: Caffeine; Cardiovascular Diseases; Cardiovascular System; Coffee; Confounding Factors, Epidemiologic | 2008 |
Malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Cold Temperature; Creatine Kinase; Dantrolene; Disease Susceptibility; H | 1983 |
[Etiological epidemiology of colorectal tumors].
Topics: Alcohol Drinking; Caffeine; Cohort Studies; Colorectal Neoplasms; Diet; Disease Susceptibility; Etha | 1996 |
[Screening tests for malignant hyperthermia susceptibility].
Topics: Animals; Caffeine; Calcium; Cholinesterases; Contracture; Creatine Kinase; Cyclic AMP; Disease Susce | 1989 |
Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
Topics: Biopsy; Caffeine; Clinical Laboratory Techniques; Disease Susceptibility; Halothane; Humans; Maligna | 1989 |
Diagnosis of susceptibility to malignant hyperthermia in man.
Topics: Caffeine; Chemistry, Clinical; Disease Susceptibility; Halothane; Hematologic Tests; Humans; In Vitr | 1988 |
5 trials available for caffeine and Diathesis
| Article | Year |
|---|---|
Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant | 2003 |
Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia.
Topics: Adult; Age Factors; Caffeine; Calcium; Calcium Signaling; Disease Susceptibility; Female; Humans; In | 2003 |
Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Contracture; Disease Susceptibility; Female; Halot | 1992 |
A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
Topics: Adolescent; Adult; Caffeine; Child; Child, Preschool; Disease Susceptibility; Female; Halothane; Hum | 1991 |
The thermogenic properties of ephedrine/methylxanthine mixtures: human studies.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Calorimetry; Disease Susceptibility; | 1986 |
117 other studies available for caffeine and Diathesis
| Article | Year |
|---|---|
Management of patients susceptible to malignant hyperthermia: A surgeon's perspective.
Topics: Caffeine; Child; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Retrospective St | 2022 |
Distinct pathophysiological characteristics in developing muscle from patients susceptible to malignant hyperthermia.
Topics: Caffeine; Calcium; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscle Contrac | 2023 |
GR/HDAC2/TGFβR1 pathway contributes to prenatal caffeine induced-osteoarthritis susceptibility in male adult offspring rats.
Topics: Animals; Caffeine; Disease Susceptibility; Female; Histone Deacetylase 2; Male; Osteoarthritis; Preg | 2020 |
Parental Concerns about Child and Adolescent Caffeinated Sugar-Sweetened Beverage Intake and Perceived Barriers to Reducing Consumption.
Topics: Adolescent; Caffeine; Child; Child Behavior; Diet; Disease Susceptibility; Drinking Behavior; Feedin | 2020 |
Skeletal Muscle Metabolic Dysfunction in Patients With Malignant Hyperthermia Susceptibility.
Topics: Adult; Anesthetics; Anthropometry; Caffeine; Case-Control Studies; Disease Susceptibility; Exercise | 2017 |
Abnormal calcium signalling and the caffeine-halothane contracture test.
Topics: Adult; Anesthetics, Inhalation; Caffeine; Calcium; Cells, Cultured; Disease Susceptibility; Dose-Res | 2019 |
Adenosine receptor antagonists including caffeine alter fetal brain development in mice.
Topics: Aging; Animals; Animals, Newborn; Brain; Caffeine; Cell Movement; Cognition Disorders; Disease Susce | 2013 |
Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Topics: Blotting, Western; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Cresols; D | 2014 |
Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
Topics: Adult; Anesthetics, Inhalation; Caffeine; Contracture; Disease Susceptibility; Female; Halothane; He | 2015 |
Susceptibility to seizure-induced sudden death in DBA/2 mice is altered by adenosine.
Topics: Adenosine; Animals; Caffeine; Death, Sudden; Disease Models, Animal; Disease Susceptibility; Dose-Re | 2016 |
Hypermetabolism in B-lymphocytes from malignant hyperthermia susceptible individuals.
Topics: Adult; B-Lymphocytes; Biomarkers; Caffeine; Calcium; Cell Line, Transformed; Cresols; Disease Suscep | 2016 |
An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Topics: Adult; Biopsy; Caffeine; Case-Control Studies; Disease Susceptibility; Female; Halothane; Humans; La | 2008 |
Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
Topics: Animals; Caffeine; Catalepsy; Central Nervous System Stimulants; Disease Susceptibility; Dopamine D2 | 2009 |
Effects of early postnatal caffeine exposure on seizure susceptibility of rats are age- and model-dependent.
Topics: Age Factors; Analysis of Variance; Animals; Caffeine; Convulsants; Disease Susceptibility; Dose-Resp | 2010 |
Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Topics: Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; Dose-R | 2011 |
Effects of Mg(2+) and SR luminal Ca(2+) on caffeine-induced Ca(2+) release in skeletal muscle from humans susceptible to malignant hyperthermia.
Topics: Caffeine; Calcium; Disease Susceptibility; Humans; Magnesium; Malignant Hyperthermia; Muscle, Skelet | 2002 |
Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility.
Topics: Adult; Anesthetics, Inhalation; Biopsy; Caffeine; Disease Susceptibility; Female; Halothane; Humans; | 2002 |
"Noninvasive" testing for malignant hyperthermia susceptibility.
Topics: Caffeine; Calcium; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscl | 2002 |
Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
Topics: Adolescent; Adult; B-Lymphocytes; Caffeine; Calcium; Child; Cresols; Disease Susceptibility; Halotha | 2002 |
Natural decaf could brew trouble for farmers.
Topics: Agriculture; Caffeine; Coffee; Disease Susceptibility; Plant Diseases; Plants, Genetically Modified | 2003 |
[ETIOLOGY OF THE DUODENAL ULCER].
Topics: Aspirin; Caffeine; Disease Susceptibility; Duodenal Ulcer; Genetics, Medical; Humans; Hyperparathyro | 1964 |
Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.
Topics: Caffeine; Calcium; Cells, Cultured; Cycloheximide; Cyclosporine; Disease Susceptibility; Homeostasis | 2004 |
Malignant hyperthermia: update on susceptibility testing.
Topics: Algorithms; B-Lymphocytes; Biopsy; Caffeine; Disease Susceptibility; DNA Mutational Analysis; Haloth | 2005 |
The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Topics: Anesthetics, Inhalation; Animals; Caffeine; Carbon Dioxide; Disease Susceptibility; Dose-Response Re | 2006 |
Effects of postnatal caffeine exposure on seizure susceptibility in developing rats.
Topics: Age Factors; Aminophylline; Animals; Animals, Newborn; Behavior, Animal; Bicuculline; Caffeine; Cent | 2007 |
Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Kinetics; Lactates; Malignant Hyperthermia; Mi | 2008 |
Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine.
Topics: Analysis of Variance; Animals; Caffeine; Disease Models, Animal; Disease Susceptibility; Dose-Respon | 2008 |
Investigation of malignant hyperthermia in Denmark and Sweden.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Creatine Kinase; Disease Susceptibility; Female; G | 1984 |
A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
Topics: Biopsy; Caffeine; Disease Susceptibility; Genetic Testing; Halothane; Humans; In Vitro Techniques; M | 1984 |
In vitro contracture tests for susceptibility to malignant hyperthermia.
Topics: Caffeine; Disease Susceptibility; Drug Interactions; Halothane; Humans; Malignant Hyperthermia; Musc | 1983 |
Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma.
Topics: Animals; Body Temperature; Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; | 1983 |
Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Disease Susceptibility; Malignant Hyperthermia; Muscle Contraction; Musc | 1983 |
C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
Topics: Adolescent; Adult; Aged; Base Sequence; Caffeine; Calcium Channels; Child; Child, Preschool; Chromos | 1995 |
Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Topics: Adult; Biopsy; Caffeine; Cocaine; Contracture; Disease Susceptibility; Female; Halothane; Humans; Ma | 1995 |
[Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Caffeine; Contracture; Creatine Kinase; Dantrolene; Di | 1994 |
Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesia, Conduction; Anes | 1995 |
Malignant hyperthermia during sevoflurane administration.
Topics: Adult; Anesthetics; Caffeine; Disease Susceptibility; Ethers; Female; Halothane; Humans; Malignant H | 1995 |
Caffeine stimulation of malignant hyperthermia-susceptible sarcoplasmic reticulum Ca2+ release channel.
Topics: Animals; Caffeine; Calcium Channels; Disease Susceptibility; Electrophysiology; Hydrogen-Ion Concent | 1994 |
Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
Topics: Adolescent; Biopsy; Caffeine; Child; Child, Preschool; Creatine Kinase; Disease Susceptibility; Fema | 1994 |
Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
Topics: Adult; Biopsy; Caffeine; Child; Disease Susceptibility; Family; Fatal Outcome; Female; Halothane; Hu | 1994 |
Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Me | 1994 |
[Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Topics: Adult; Caffeine; Child; Child, Preschool; Disease Susceptibility; Halothane; Humans; In Vitro Techni | 1993 |
The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndrome.
Topics: Adult; Arteriosclerosis; Caffeine; Dietary Fats; Disease Susceptibility; Fasting; Fatty Acids; Human | 1993 |
Fiber-type caffeine sensitivities in skinned muscle fibers from humans susceptible to malignant hyperthermia.
Topics: Caffeine; Disease Susceptibility; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscles | 1993 |
Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Disease Susceptibility; Female; Halothane; Humans; Magnet | 1993 |
Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Topics: Caffeine; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Tech | 1993 |
On the nature of the link between malignant hyperthermia and exertional heatstroke.
Topics: Animals; Body Temperature Regulation; Caffeine; Calcium Channels; Disease Models, Animal; Disease Su | 1995 |
Neonatal caffeine exposure alters seizure susceptibility in rats in an age-related manner.
Topics: Aging; Analysis of Variance; Animals; Animals, Newborn; Caffeine; Convulsants; Disease Susceptibilit | 1995 |
Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Topics: Anesthetics, Inhalation; Caffeine; Disease Susceptibility; Female; Halothane; Heterozygote; Humans; | 1996 |
Malignant hyperthermia.
Topics: Anesthesia, General; Caffeine; Counseling; Disease Susceptibility; Halothane; Humans; Malignant Hype | 1996 |
Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding.
Topics: Animals; Autoradiography; Behavior, Animal; Bicuculline; Brain; Caffeine; Disease Susceptibility; Ma | 1996 |
[Definition of a diagnostic score of malignant hyperthermia using P-31 magnetic resonance spectroscopy].
Topics: Caffeine; Contracture; Disease Susceptibility; Halothane; Humans; Magnetic Resonance Spectroscopy; M | 1996 |
An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Contracture; Disease Susceptibility; Halothane; Hu | 1997 |
Rapid, simple and sensitive microassay for skeletal muscle homogenates in the functional assessment of the Ca-release channel of sarcoplasmic reticulum: application to diagnosis of susceptibility to malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Calcium-Transporting ATPases; Disease Models, Animal; | 1997 |
Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Biopsy, Needle; Caffeine; Child; Child, Preschool; Clini | 1997 |
Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Caffeine; Cresols; Disease Susceptibility; Dose-Re | 1997 |
Clinical reassessment of malignant hyperthermia in Abitibi-Témiscamingue.
Topics: Adolescent; Adult; Caffeine; Child; Disease Susceptibility; Family Characteristics; Female; Halothan | 1997 |
[Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Topics: Adolescent; Adult; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques | 1997 |
Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study.
Topics: Anesthetics, Inhalation; Animals; Caffeine; Disease Susceptibility; Dystrophin; Halothane; Male; Mal | 1997 |
4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Huma | 1997 |
Muscle biopsy for malignant hyperthermia screening in children.
Topics: Adolescent; Anesthetics, Inhalation; Biopsy; Caffeine; Central Nervous System Stimulants; Child; Dis | 1997 |
Anxiety sensitivity and self-reported reasons for drug use.
Topics: Adaptation, Psychological; Adolescent; Adult; Alcohol Drinking; Anxiety; Caffeine; Disease Susceptib | 1997 |
Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia.
Topics: Adult; Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; | 1998 |
Effects of halothane on mechanical response of skeletal muscle from malignant hyperthermia susceptible patients.
Topics: Anesthetics, Inhalation; Biopsy; Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techn | 1998 |
[Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia].
Topics: Caffeine; Disease Susceptibility; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contra | 1999 |
[Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
Topics: Adult; Caffeine; Contracture; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hyp | 2000 |
[Phenotyping of cytochrome P-450 1A2 and N-acetyltransferase (NAT2) using the in vivo caffeine test as a tool for determining individual susceptibility to selected xenobiotics].
Topics: Arylamine N-Acetyltransferase; Caffeine; Carcinogens; Chromatography, High Pressure Liquid; Cytochro | 1999 |
Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test.
Topics: Adult; Caffeine; Carbon Dioxide; Case-Control Studies; Disease Susceptibility; Female; Humans; Male; | 2002 |
Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Topics: Anesthesia, Inhalation; Animals; Caffeine; Disease Susceptibility; Dog Diseases; Dogs; Genetic Predi | 1992 |
Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
Topics: Caffeine; Culture Techniques; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Mus | 1992 |
Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
Topics: Adolescent; Adult; Anesthesia, Intravenous; Caffeine; Contracture; Disease Susceptibility; Halothane | 1992 |
[Effects of halothane, caffeine and ryanodine on the intracellular calcium store in blood mononuclear cells].
Topics: Animals; Caffeine; Calcium; Disease Susceptibility; Halothane; Humans; Leukocytes, Mononuclear; Mali | 1992 |
Evidence for related myopathies in exertional heat stroke and malignant hyperthermia.
Topics: Adult; Biopsy; Caffeine; Disease Susceptibility; Family Health; Female; Halothane; Heat Exhaustion; | 1991 |
Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
In vitro contracture tests in patients with various neuromuscular diseases.
Topics: Adolescent; Adult; Aged; Caffeine; Child; Child, Preschool; Disease Susceptibility; Drug Hypersensit | 1992 |
[A new emphasis on the diagnosis of malignant hyperthermia using the in vitro contracture test?].
Topics: Adolescent; Adult; Caffeine; Child; Child, Preschool; Disease Susceptibility; Halothane; Humans; In | 1991 |
[Diagnosis of malignant hyperthermia. The platelet test versus the in vitro contracture test].
Topics: Blood Platelets; Caffeine; Child; Disease Susceptibility; Halothane; Humans; Male; Malignant Hyperth | 1991 |
In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis.
Topics: Adult; Caffeine; Calcium; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hyperth | 1991 |
In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
Topics: Caffeine; Chromatography, Gas; Contracture; Diffusion Chambers, Culture; Disease Susceptibility; Ele | 1991 |
Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Isoproterenol; Malignant Hyperthermia; Myocard | 1991 |
Characterization of swine susceptible to malignant hyperthermia by in vivo, in vitro and post-mortem techniques.
Topics: Administration, Inhalation; Animals; Caffeine; Creatine Kinase; Disease Susceptibility; Genotype; Ha | 1991 |
Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures.
Topics: Adult; Biopsy; Caffeine; Calcium; Disease Susceptibility; False Negative Reactions; Female; Halothan | 1991 |
The caffeine contracture test for malignant hyperthermia: caffeine citrate, caffeine benzoate or caffeine free base?
Topics: Animals; Benzoates; Caffeine; Citrates; Disease Susceptibility; Drug Combinations; Male; Malignant H | 1991 |
Halothane-dependent release of intracellular Ca2+ in blood cells in malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Cytosol; Disease Susceptibility; Egtazic Acid; Halothane; Humans; Malign | 1990 |
Fiber-type specific caffeine sensitivities in normal human skinned muscle fibers.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Caffeine; Calcium; Child; Disease Susceptibility; Drug | 1990 |
Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
Topics: Biopsy; Caffeine; Calcium; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant | 1990 |
Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; In Vitro Techniques; Malignant Hyperthermia; M | 1990 |
Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
Topics: Caffeine; Disease Susceptibility; False Negative Reactions; Halothane; Humans; In Vitro Techniques; | 1990 |
Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
Topics: Anesthesia, General; Caffeine; Contracture; Disease Susceptibility; Halothane; Humans; Malignant Hyp | 1990 |
Current diagnostic methods of malignant hyperthermia: an evaluation.
Topics: Caffeine; Chromosomes, Human, Pair 19; Disease Susceptibility; Halothane; Humans; Magnetic Resonance | 1990 |
Compensatory increase in calcium extrusion activity of untreated lymphocytes from swine susceptible to malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Disease Susceptibility; Halothane; Lymphocytes; Malignant Hyperthermia; | 1990 |
Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites.
Topics: Acetylation; Arylamine N-Acetyltransferase; Biotransformation; Caffeine; Cytochrome P-450 Enzyme Sys | 1990 |
Malignant hyperthermia: slow sodium current in cultured human muscle cells.
Topics: Caffeine; Cells, Cultured; Disease Susceptibility; Electric Conductivity; Halothane; Humans; Maligna | 1989 |
The association between the neuroleptic malignant syndrome and malignant hyperthermia.
Topics: Adult; Caffeine; Chlorpromazine; Contracture; Disease Susceptibility; Female; Halothane; Humans; Mal | 1989 |
Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
Topics: Caffeine; Dantrolene; Diltiazem; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Mal | 1989 |
[The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Topics: Caffeine; Disease Susceptibility; Halothane; In Vitro Techniques; Ketamine; Malignant Hyperthermia; | 1989 |
Fluoxetine treatment of a depressed patient susceptible to malignant hyperthermia.
Topics: Adolescent; Caffeine; Depressive Disorder; Disease Susceptibility; Female; Fluoxetine; Halothane; Hu | 1989 |
Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
Topics: Anesthesia; Caffeine; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; H | 1989 |
Different genes specify hyporesponsiveness to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM.
Topics: Animals; Caffeine; Carbolines; Crosses, Genetic; Disease Susceptibility; Genes; Genetics, Behavioral | 1987 |
Malignant hyperthermia in plastic surgery.
Topics: Adult; Caffeine; Child; Child, Preschool; Dermoid Cyst; Disease Susceptibility; Facial Neoplasms; Fe | 1988 |
[Tests of contracture and sensitivity to malignant hyperthermia in 27 patients].
Topics: Adolescent; Adult; Anesthesia, General; Biopsy; Caffeine; Child; Child, Preschool; Contracture; Crea | 1988 |
Confounders contributing to the reported associations of coffee or caffeine with disease.
Topics: Adult; Aged; Caffeine; Coffee; Coronary Disease; Disease Susceptibility; Drinking Behavior; Female; | 1988 |
Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs.
Topics: Animals; Benzofurans; Caffeine; Calcium; Disease Susceptibility; Fura-2; Halothane; Malignant Hypert | 1988 |
[Malignant hyperthermia in Austria. II. A comparison of the results of diagnostic test procedures].
Topics: Adult; Caffeine; Creatine Kinase; Disease Susceptibility; Electromyography; Female; Halothane; Human | 1988 |
Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.
Topics: Adult; Aged; Caffeine; Disease Susceptibility; Female; Halothane; Humans; In Vitro Techniques; Male; | 1987 |
In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Topics: Caffeine; Disease Susceptibility; Evaluation Studies as Topic; Halothane; Humans; In Vitro Technique | 1987 |
In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Mu | 1987 |
Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Male; Malignant Hypertherm | 1986 |
Malignant hyperthermia.
Topics: Adult; Anesthesia; Animals; Caffeine; Child; Creatine Kinase; Disease Susceptibility; Halothane; Hum | 1985 |
Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
Topics: Biopsy; Caffeine; Clinical Enzyme Tests; Creatine Kinase; Disease Susceptibility; Humans; In Vitro T | 1986 |
Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Hybridization, Genetic; In Vitro Techniques; M | 1986 |
Malignant hyperpyrexia and sudden death.
Topics: Adolescent; Adult; Caffeine; Death, Sudden; Disease Susceptibility; Halothane; Humans; Male; Maligna | 1985 |
In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
Topics: Caffeine; Disease Susceptibility; Drug Interactions; Halothane; Humans; In Vitro Techniques; Maligna | 1985 |
Laboratory diagnosis of malignant hyperpyrexia susceptibility (MHS). European MH Group.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia | 1985 |
Microcalorimetric studies in malignant hyperpyrexia susceptible individuals.
Topics: Blood Platelets; Body Temperature Regulation; Caffeine; Calorimetry; Disease Susceptibility; Halotha | 1985 |
Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
Topics: Animals; Benzazepines; Caffeine; Depression, Chemical; Diltiazem; Disease Susceptibility; Halothane; | 1985 |
Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?
Topics: Adenylate Kinase; Adult; AMP Deaminase; Caffeine; Creatine Kinase; Disease Susceptibility; Female; H | 1985 |